BRIEF

on Zomedica Corp. (NASDAQ:ZOM)

Zomedica Partners with VMG for Advanced Veterinary Technologies

Zomedica Corp. has announced a strategic partnership with Veterinary Management Groups (VMG), effective from September 1, 2026, to August 31, 2028. This partnership positions Zomedica as a preferred provider of advanced veterinary solutions to over 2,000 VMG members across the U.S. The collaboration aims to deliver cutting-edge technologies to independent veterinary practices.

VMG members will gain preferred access to Zomedica's range of technologies, including the PulseVet® shock wave therapy system, Assisi® tPEMF™ devices, VETIGEL® hemostatic gel, the TRUFORMA® diagnostic platform, and the VETGuardian PLUS™ monitoring system. These products are designed to enhance clinical outcomes and improve operational efficiency in veterinary care.

Leaders from both organizations have expressed excitement about the partnership's potential to elevate veterinary practice and support member success through innovative solutions.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Zomedica Corp. news